21 results
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockersâ €
Class II
Class I agents ... Channel Blockersâ € Class ... agents in this class ... beta blockers.â € Class ... Channel Blockers Class
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table ... comparison #management #medications
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
by Antibiotic Class ... study-specific risk ... by antibiotic class ... #Pharmacology #Class ... #Clostridium #Table
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
Antianginal Drugs DRUG CLASS ... #Antianginal #Medications ... Management #Therapy #Table
A priority in this project was to appropriately stratify participants into a low, medium, or high-intensity
group-based exercise class ... CDC, entitled “Algorithm ... for Fall Risk Assessment ... The algorithm is ... #Fall #Risk #Screening
Antiarrhythmics - Sodium Channel Blockers
Subclasses, Mechanisms, Indications, Side Effects
la - Quinidine, Procainamide
lb - Lidocaine, Mexiletine
Ic -
Subclasses, Mechanisms, Indications ... Channel #Blockers #ClassI ... #pharmacology #table
Recommendations for initial management of Unstable Angina/NSTEMI

Flowchart for class I and class lla recommendations for initial
Flowchart for class ... I and class lla ... UnstableAngina #Management #Algorithm ... #Cardiology #Medication
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism - Risk ... PE-related) • PESI class ... Hemodynamics (Stable ... Pulmonary #Embolism #Risk
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... metabolic equivalent able ... ASA class If ... event, follow ACC algorithm ... Stable patients
Fibrates - Gemfibrozil and Fenofibrate 
Mechanism: activates PPAR alpha
Lipid Effects:
 - Decrease TG by 30-50%
 -
The Fibrate drug class ... These 2 medications ... either of these medications ... increases the risk